T1	Participants 58 182	patients with type 2 diabetes mellitus and coronary artery disease on dual antiplatelet therapy with aspirin and clopidogrel
T2	Participants 834 896	DM patients with stable coronary artery disease receiving DAPT
T3	Participants 2107 2162	DM patients with coronary artery disease receiving DAPT
